Table 3 |
|||||||
|
Age breakdown for base case and for three sensitivity analyses |
|||||||
| Artesunate plus SP |
Artemether – lumefantrine |
||||||
|
|
|||||||
| Age (years) |
1 – 6 |
7 – 13 |
14+ |
1 – 5 |
6 – 8 |
9 – 12 |
13+ |
|
|
|||||||
| Base case |
28.3% |
15.3% |
56.4% |
23.6% |
9.1 |
8.7 |
58.6 |
| Age breakdown 1 |
50% |
15% |
35% |
45% |
9% |
9% |
37% |
| Age breakdown 2 |
40% |
20% |
40% |
35% |
11.5% |
11.5% |
42% |
| Age breakdown 3 |
10% |
5% |
85% |
8% |
2% |
2% |
88% |
|
|
|||||||
|
Zikusooka et al. Malaria Journal 2008 7:176 doi:10.1186/1475-2875-7-176 |
|||||||